StockData
Biomerica Inc logo

Biomerica Inc (BMRA) shareholders

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.24−0.08 (-6.44%)

Close on Nov 17, 2026Market cap $5.68MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
2.7%
0M of 5M shares
Institutional holders
20
9 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $158.00K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BRC Group Holdings, Inc.
Joint filing with B. Riley Principal Capital, LLC (10.03%), Bryant R. Riley (10.03%)
460,08010.03%13D (active)Aug 25, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BMRAValueChange% of portfolio
Hrt Financial LP26,3740.57%$46.00KNew0.00%
Geode Capital Management, LLC24,3470.53%$42.86K−31,6950.00%
BlackRock, Inc.18,6360.41%$32.80K–0.00%
Vanguard Capital Management LLC14,5140.32%$25.55K–0.00%
Jane Street Group, LLC12,6400.27%$22.25KNew0.00%
LPL Financial LLC10,8490.24%$19.09K–0.00%
UBS Group AG6,9510.15%$12.23K+6,4320.00%
Vanguard Fiduciary Trust Co6,6130.14%$11.64K–0.00%
NewEdge Advisors, LLC3,6030.08%$6.34K–0.00%
Tower Research Capital LLC (TRC)2380.01%$419New0.00%
Hollencrest Capital Management2000.00%$352−6250.00%
Harbour Investments, Inc.1250.00%$220–0.00%
FMR LLC830.00%$146New0.00%
IFG Advisory, LLC250.00%$44New0.00%
Larson Financial Group LLC120.00%$21New0.00%
Barclays PLC60.00%$11New0.00%
MCF Advisors LLC60.00%$11–0.00%
Federation des caisses Desjardins du Quebec30.00%$5New0.00%
Caitong International Asset Management Co., Ltd20.00%$4New0.00%
Danske Bank A/S10.00%$2–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026200M2.7%9 / 12 / 00M0M
Q1 2026110M2.4%4 / 12 / 40M0M
Q4 2025130M1.9%0 / 51 / 40M0M
Q3 2025170M1.9%6 / 13 / 10M0M
Q2 2025120M1.5%1 / 45 / 130M0M
Q1 2025240M2.6%6 / 36 / 30M0M
Q4 2024210M3.8%5 / 34 / 80M0M
Q3 2024250M4.4%4 / 012 / 130M0M
Q2 2024350M6.1%6 / 59 / 70M0M
Q1 2024360M10.1%9 / 87 / 40M0M
Q4 2023330M10.2%4 / 138 / 60M0M
Q3 2023350M10.9%3 / 512 / 40M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

4 funds held BMRA in Q2 2026, 23% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of BMRAValue% of fundAs of
Fidelity Extended Market Index Fund42,9430.93%$104.35K0.00%May 31, 2026
Vanguard Extended Market Index Fund14,5140.32%$25.54K0.00%Jun 30, 2026
Fidelity Series Total Market Index Fund3,4890.08%$8.48K0.00%May 31, 2026
Fidelity Total Market Index Fund1,7190.04%$4.18K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Zackary S. IraniChief Executive Officer, Director242,5705.27%Aug 27, 2026
Allen BarbieriExecutive Vice Chairman, Director73,5421.60%Aug 27, 2026
Xiaoxuan QuSee Remarks––Sep 8, 2026
Gary LuChief Financial Officer59,3751.29%Dec 31, 2025
Eric ChinDirector38,7500.84%Aug 27, 2026
M. Huff GaryDirector51,2501.11%Aug 27, 2026
David MoatazediDirector40,6250.88%Aug 27, 2026
Jane EmersonDirector156,0003.39%Dec 17, 2024
Catherine CosteDirector137,8903.00%Dec 17, 2024
Bryant R. Riley10% owner––Sep 10, 2026
B. RILEY Principal Capital, LLC10% owner––Sep 10, 2026
BRC Group Holdings, Inc.10% owner460,08010.00%Sep 10, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Zackary S. Irani
Chief Executive Officer, Director
Aug 26, 2026Buy+31,250$1.60$50.00K242,570
David Moatazedi
Director
Aug 26, 2026Buy+10,000$1.60$16.00K40,625
Allen Barbieri
Executive Vice Chairman, Director
Aug 26, 2026Buy+20,000$1.60$32.00K73,542
Eric Chin
Director
Aug 26, 2026Buy+6,250$1.60$10.00K38,750
M. Huff Gary
Director
Aug 20, 2026Buy+31,250$1.60$50.00K51,250
Eric Chin
Director
Dec 12, 2025Award+22,500––32,500
David Moatazedi
Director
Dec 12, 2025Award+20,000––30,625
Gary Lu
Chief Financial Officer
Dec 12, 2025Award+40,000––59,375
Zackary S. Irani
Chief Executive Officer, Director
Dec 12, 2025Award+52,500––211,320
M. Huff Gary
Director
Dec 12, 2025Award+20,000––20,000
Allen Barbieri
Executive Vice-Chairman, Director
Dec 12, 2025Award+30,000––53,543
David Moatazedi
Director
Dec 13, 2024Award+85,000$0.31$26.35K85,000
Allen Barbieri
Executive Vice Chairman, Director
Dec 13, 2024Award+110,000$0.31$34.10K188,337
Catherine Coste
Director
Dec 13, 2024Award+85,000$0.31$26.35K128,790
Gary Lu
Chief Financial Officer
Dec 13, 2024Award+155,000$0.31$48.05K155,000
Jane Emerson
Director
Dec 13, 2024Award+85,000$0.31$26.35K156,000
Zackary S. Irani
Chief Executive Officer, Director
Dec 13, 2024Award+250,000$0.31$77.50K1,270,560
Allen Barbieri
Vice Chairman, Director
Jan 2, 2024Gift−15,000––78,337
Allen Barbieri
Vice Chairman, Director
Jun 27, 2023Gift−8,000––93,327
Zackary S. Irani
Chief Executive Officer, Director
May 25, 2023Buy+200$1.55$3101,020,560
Zackary S. Irani
Chief Executive Officer, Director
May 24, 2023Buy+500$1.61$8051,020,360
Zackary S. Irani
Chief Executive Officer, Director
May 12, 2023Buy+1,700$1.17$1.99K1,019,860
Zackary S. Irani
Chief Executive Officer, Director
May 10, 2023Buy+500$1.27$6351,018,160
Zackary S. Irani
Chief Executive Officer, Director
May 9, 2023Buy+300$1.39$4171,017,660
Zackary S. Irani
Chief Executive Officer, Director
May 4, 2023Buy+1,000$1.36$1.36K1,017,360
Zackary S. Irani
Chief Executive Officer, Director
Apr 28, 2023Buy+1,800$1.34$2.41K1,017,360
Zackary S. Irani
Chief Executive Officer, Director
Apr 27, 2023Buy+2,600$1.31$3.41K1,017,360
Zackary S. Irani
Chief Executive Officer, Director
Apr 26, 2023Buy+7,000$1.26$8.82K1,012,960
Allen Barbieri
Executive Vice Chairman, Director
Jan 27, 2023Buy+1,538$2.94$4.52K101,327
Catherine Coste
Director
Jan 26, 2023Buy+2,190$2.96$6.48K43,790
Zackary S. Irani
Chief Executive Officer, Director
Jan 25, 2023Buy+1,800$2.85$5.13K1,005,960
Zackary S. Irani
Chief Executive Officer, Director
Jan 24, 2023Buy+2,000$2.81$5.62K1,004,160
Allen Barbieri
Vice Chairman, Director
Nov 17, 2022Gift−7,500––101,327
Allen Barbieri
Vice Chairman, Director
Dec 20, 2021Gift−7,500––107,289
Allen Barbieri
Vice Chairman, Director
Mar 26, 2021Gift−22,500––114,789
Allen Barbieri
Vice Chairman, Director
Mar 26, 2021Gift−22,500––114,789
Catherine Coste
Director
Oct 26, 2020Buy+9,100$5.45$49.60K9,100
Francis Cano
Director
Oct 5, 2020Gift−20,000––146,736
Mark A. Sirgo
Director
Apr 21, 2020Sale−5,000$8.11$40.55K8,700
Mark A. Sirgo
Director
Apr 17, 2020Sale−1,302$8.07$10.51K16,154
Mark A. Sirgo
Director
Apr 17, 2020Sale−68$8.09$55018,632
Mark A. Sirgo
Director
Apr 17, 2020Sale−100$8.06$80618,532
Mark A. Sirgo
Director
Apr 17, 2020Sale−2,454$8.08$19.83K13,700
Mark A. Sirgo
Director
Apr 17, 2020Sale−1,076$8.05$8.66K17,456
Allen Barbieri
Director
Apr 1, 2020Gift−23,000––137,289
Zackary S. Irani
Chief Executive Officer, Director
Feb 28, 2020Other+78,431$2.85$223.53K1,002,160
Janet Moore
Chief Financial Officer, Director
Jan 2, 2020Gift−20,000––101,720
Janet Moore
Chief Financial Officer, Director
Oct 28, 2019Gift−3,000––121,720
Janet Moore
Chief Financial Officer, Director
Apr 23, 2019Gift−16,000––124,720
Zackary S. Irani
Chief Executive Officer, Director
Dec 21, 2018Other+2,000$1.82$3.64K922,129
Zackary S. Irani
Chief Executive Officer, Director
Dec 21, 2018Other+600$2.04$1.22K923,729
Zackary S. Irani
Chief Executive Officer, Director
Dec 21, 2018Other+1,000$2.05$2.05K923,129
Zackary S. Irani
Chief Executive Officer, Director
Dec 20, 2018Other+400$2.45$980920,129
Zackary S. Irani
Chief Executive Officer, Director
Dec 19, 2018Other+400$2.47$988919,329
Zackary S. Irani
Chief Executive Officer, Director
Dec 19, 2018Other+400$2.45$980919,729
Zackary S. Irani
Chief Executive Officer, Director
Dec 7, 2018Other+33,390$2.70$90.15K918,929
Francis Cano
Director
Oct 26, 2018Option exercise+25,000$0.75$18.75K166,736
Allen Barbieri
Director
Oct 19, 2018Option exercise+25,000$0.75$18.75K160,289
Jane Emerson
Director
Oct 5, 2018Option exercise+25,000$0.75$18.75K71,000
Zackary S. Irani
Chief Executive Officer, Director, 10% owner
May 23, 2018Other+25,000$3.73$93.25K885,539

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.37%
0M shares short
Days to cover
1.5
At 0M shares a day
Change since last report
+16.5%
From 0M shares
Short volume, 20 days
30.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Biomerica's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,582 shares on Aug 28, 2026 over the last 90 days.

See a number that looks wrong?